You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SCLC

Showing 26 - 50 of 720
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

Not yet recruiting
  • Relapsed Small Cell Lung Cancer
  • Irinotecan hydrochloride liposome Injection
  • Topotecan
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023

Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)

Completed
  • Lung Cancer
    • Barcelona, Spain
    • +1 more
    Jan 11, 2022

    Small-cell Lung Cancer Trial in New York (Carboplatin, Etoposide, Atezolizumab)

    Recruiting
    • Small-cell Lung Cancer
    • New York, New York
      Columbia University Irving Medical Center, Herbert Irving Compre
    Apr 7, 2022

    Lung Tumors Trial (Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy), Envafolimab combined

    Not yet recruiting
    • Lung Neoplasms
    • Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy)
    • Envafolimab combined with concurrent chemoradiotherapy (Conventional Radiotherapy)
    • (no location specified)
    Jun 12, 2023

    Small-cell Lung Cancer, Brain Metastases Trial in United States (Carboplatin, Etoposide, Atezolizumab)

    Active, not recruiting
    • Small-cell Lung Cancer
    • Brain Metastases
    • Duarte, California
    • +5 more
    Oct 10, 2022

    Extensive-stage Small-cell Lung Cancer Trial in Haikou (Trilaciclib)

    Active, not recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Haikou, Hainan, China
      Hainan General Hospital
    Jun 13, 2022

    Extensive Stage Small Cell Lung Cancer Trial in France ([177Lu]Lu-DOTA-TATE, Tislelizumab, [68Ga]Ga-DOTA-TATE)

    Recruiting
    • Extensive Stage Small Cell Lung Cancer
    • Lille, France
    • +6 more
    Jan 23, 2023

    Outcomes ofBrazilian Cohort of Previously Untreated Extensive

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Observational study
    • (no location specified)
    Aug 24, 2023

    Extensive Stage Small Cell Lung Carcinoma Trial in United States (Pembrolizumab, Laboratory Biomarker Analysis)

    Active, not recruiting
    Has Results
    • Extensive Stage Small Cell Lung Carcinoma
    • Pembrolizumab
    • Laboratory Biomarker Analysis
    • Chicago, Illinois
    • +4 more
    Jun 28, 2022

    Extensive-stage Small-cell Lung Cancer Trial (Surufatinib Durvalizumab EP/EC)

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Surufatinib Durvalizumab EP/EC
    • (no location specified)
    Dec 20, 2022

    SCLC,Extensive Stage Trial in Italy (Pembrolizumab/Olaparib)

    Not yet recruiting
    • SCLC,Extensive Stage
    • Meldola, Forlì Cesena, Italy
    • +9 more
    Nov 11, 2022

    SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

    Recruiting
    • SCLC
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    SCLC, NSCLC Trial (MILs™ in Combination with Pembrolizumab)

    Withdrawn
    • SCLC
    • NSCLC
    • MILs™ in Combination with Pembrolizumab
    • (no location specified)
    Oct 1, 2021

    Small Cell Lung Cancer (SCLC) Trial in Beijing (JK-1201I)

    Recruiting
    • Small Cell Lung Cancer (SCLC)
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Dec 14, 2021

    Small Cell Lung Cancer (SCLC) Trial in New York (biological, drug, radiation)

    Terminated
    Has Results
    • Small Cell Lung Cancer (SCLC)
    • Pembrolizumab
    • +4 more
    • New York, New York
      Laura and Isaac Perlmutter Cancer Center at NYU Langone
    Oct 18, 2021

    Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation

    Not yet recruiting
    • Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation Sequencing (NGS) Panel (>30 Genes)
    • Minimal documentation
    • Extended documentation
    • Mannheim, Baden-Württemberg, Germany
    • +1 more
    Jan 18, 2023

    Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

    Not yet recruiting
    • Small Cell Lung Cancer Extensive Stage
    • Jinan, China
    • +2 more
    Sep 10, 2023

    Extensive Small Cell Lung Cancer Trial in Jinan (Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy)

    Recruiting
    • Extensive Small Cell Lung Cancer
    • Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
    • Jinan, Shan Dong, China
      The First Affiliated Hospital of Shandong First Medical Universi
    Nov 6, 2023

    Phase 1, NSCLC, SCLC Trial in United States (Oral MRT-2359)

    Recruiting
    • NSCLC
    • +6 more
    • Oral MRT-2359
    • Scottsdale, Arizona
    • +7 more
    Dec 20, 2022

    Extensive Stage Small Cell Lung Cancer Trial in Hangzhou (Tislelizumab, Anlotinib)

    Recruiting
    • Extensive Stage Small Cell Lung Cancer
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Jun 6, 2023

    Extensive Stage Small Cell Lung Cancer Trial in Shanghai (HLX10, carboplatin and etoposide, )

    Active, not recruiting
    • Extensive Stage Small Cell Lung Cancer
    • Shanghai, China
    • +5 more
    Sep 28, 2022

    SCLC,Extensive Stage, SLFN11-positive Trial in Worldwide (Niraparib)

    Not yet recruiting
    • SCLC,Extensive Stage
    • SLFN11-positive
    • Angers, France
    • +19 more
    Jan 30, 2023

    Extensive-stage Small-cell Lung Cancer Trial in Pittsburgh (Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection,

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Durvalumab 50 MG/1 ML Intravenous Solution
    • +4 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Oct 31, 2022

    Online Adaptive Radiotherapy UsingNovel Linear Accelerator

    Recruiting
    • Prostate Cancer
    • +8 more
    • Online adaptive radiation therapy
    • Berlin, Germany
      Charité - Universitätsmedizin
    Oct 30, 2023

    Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

    Not yet recruiting
    • Small-cell Lung Cancer
    • Neuroendocrine Carcinoma
    • (no location specified)
    Jun 13, 2022